Sara Bringhen (S Bringhen)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Venues

Blood cancer journal

Cancers

Expert review of hematology

American journal of hematology

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino Apr 01 2005

Italy

MD :: Myeloma Unit, Division of Hematology

Publications

Massimo Martino, Barbara Gamberi, Elisabetta Antonioli, Sara Aquino, Roberta Della Pepa, Lara Malerba, Silvia Mangiacavalli, Sara Pezzatti, Sara Bringhen, Elena Zamagni
Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this? Expert review of hematology 17 (7) (2024)
Anna Colomba, Anna Astarita, Giulia Mingrone, Lorenzo Airale, Cinzia Catarinella, Fabrizio Vallelonga, Dario Leone, Marco Cesareo, Arianna Paladino, Sara Bringhen, Francesca Gay, Gianni Pedrizzetti, Franco Veglio, Alberto Milan
Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment. Cancers 16 (17) (2024)
Massimo Martino, Barbara Gamberi, Elisabetta Antonioli, Sara Aquino, Roberta Della Pepa, Lara Malerba, Silvia Mangiacavalli, Sara Pezzatti, Sara Bringhen, Elena Zamagni
Anti-BCMA CAR-T cell-based therapies and bispecific antibodies in the immunotherapy era: are we ready for this? Expert review of hematology (2024)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Giulia Benevolo, Giuseppe Bertuglia, Sara Bringhen, Francesca Maletta, Benedetto Bruno
An atypical presentation of visceral leishmaniasis mimicking multiple myeloma relapse. American journal of hematology (2023)
Alessandra Larocca, Lorenzo Cani, Giuseppe Bertuglia, Benedetto Bruno, Sara Bringhen
New Strategies for the Treatment of Older Myeloma Patients. Cancers 15 (10) (2023)
Enrique María Ocio, Aurore Perrot, Pierre Bories, Jesús San F Miguel, Igor W Blau, Lionel Karlin, Joaquin Martinez-Lopez, Song-Yau Wang, Sara Bringhen, Magda Marcatti, Maria-Victoria Mateos-Manteca, Paula Rodriguez Otero, Stefania Oliva, Axel Nogai, Nadia Le Roux, Liyan Dong, Sandrine Macé, Matthieu Gassiot, Thomas Fitzmaurice, Corina Oprea, Phillipe Moreau
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation. Leukemia (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Hira S Mian, Arleigh McCurdy, Smith Giri, Shakira J Grant, Bram Rochwerg, Erica Winks, Ashley E Rosko, Monika Engelhardt, Charlotte Pawlyn, Curly T C M Morris, Graham Jackson, Sara Bringhen, Thierry Facon, Alessandra Larocca, Sonja Zweegman, Tanya M Wildes
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review. Blood cancer journal 13 (1) (2023)
Roberto Mina, Antonietta Pia Falcone, Sara Bringhen, Anna Marina Liberati, Norbert Pescosta, Maria Teresa Petrucci, Giovannino Ciccone, Andrea Capra, Francesca Patriarca, Delia Rota-Scalabrini, Francesca Bonello, Caterina Musolino, Michele Cea, Renato Zambello, Paola Tacchetti, Angelo Belotti, Claudia Cellini, Laura Paris, Mariella Grasso, Sara Aquino, Lorenzo De Paoli, Giovanni De Sabbata, Stelvio Ballanti, Massimo Offidani, Mario Boccadoro, Federico Monaco, Paolo Corradini, Alessandra Larocca
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial. Blood cancer journal 11 (12) (2021)
Anna Astarita, Giulia Mingrone, Lorenzo Airale, Fabrizio Vallelonga, Michele Covella, Cinzia Catarinella, Marco Cesareo, Giulia Bruno, Dario Leone, Carlo Giordana, Giusy Cetani, Marco Salvini, Francesca Gay, Sara Bringhen, Franco Rabbia, Franco Veglio, Alberto Milan
Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction. Cancers 13 (7) (2021)
Mattia D'Agostino, Alessandra Larocca, Massimo Offidani, Anna Marina Liberati, Gianluca Gaidano, Maria Teresa Petrucci, Daniele Derudas, Andrea Capra, Renato Zambello, Nicola Cascavilla, Paolo de Fabritiis, Vanessa Innao, Francesca Bonello, Francesca Patriarca, Giulia Benevolo, Nicola Giuliani, Gabriele Aitoro, Tommasina Guglielmelli, Francesco Di Raimondo, Paolo Corradini, Pellegrino Musto, Roman Hájek, Pieter Sonneveld, Mario Boccadoro, Sara Bringhen
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score. Blood cancer journal 11 (4) (2021)
Sara Bringhen, Peter M Voorhees, Torben Plesner, Ulf-Henrik Mellqvist, Brandi Reeves, Pieter Sonneveld, Catriona Byrne, Eva Nordström, Johan Harmenberg, Jakob Obermüller, Paul Gerard Richardson
Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long-term survival follow-up from the Phase II study O-12-M1. British journal of haematology 193 (6) (2021)
Luca Bertamini, Francesca Bonello, Mario Boccadoro, Sara Bringhen
New drugs in early development for treating multiple myeloma: all that glitters is not gold. Expert opinion on investigational drugs 29 (9) (2020)
Mattia D'Agostino, Salvatore Innorcia, Mario Boccadoro, Sara Bringhen
Monoclonal Antibodies to Treat Multiple Myeloma: A Dream Come True. International journal of molecular sciences 21 (21) (2020)
Francesca Bonello, Mariella Grasso, Mattia D'Agostino, Ivana Celeghini, Alessia Castellino, Mario Boccadoro, Sara Bringhen
The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma. Pharmaceuticals (Basel, Switzerland) 14 (1) (2020)
Sara Bringhen, A Milan, M D'Agostino, C Ferri, R Wäsch, F Gay, A Larocca, M Offidani, S Zweegman, E Terpos, H Goldschmidt, M Cavo, H Ludwig, C Driessen, H W Auner, J Caers, M Gramatzki, M A Dimopoulos, M Boccadoro, H Einsele, P Sonneveld, M Engelhardt
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension. Journal of internal medicine 286 (1) (2019)

Sara Bringhen.css-eqlu8i{font-size:small;padding-left:4px;} (S Bringhen)

Publication Activity (10 Years)

Top Topics

Top Venues

Sara Bringhen (S Bringhen)